Green shoots of spring recovery in COVID-19 medical supplies to U.S. — Panjiva
MENU

Green shoots of spring recovery in COVID-19 medical supplies to U.S.

Canada 529 China 3048 Coronavirus 511 European Union 878 Health Care 362 Malaysia 160 Mexico 928 Singapore 71 Tariffs 1866 U.S. 5399

The U.S. Congress has commissioned a report into the trade and tariff characteristics of medical supplies as part of the process of tackling COVID-19. A report is due by April 30. This Panjiva research report looks at products that might be included including their recent trade performance. Considering 16 products identified by a Federal Reserve analysis across PPE, diagnostics and treatment equipment shows the U.S. imported $30.8 billion worth of supplies in 2019. Of those 24.2% were sourced from China, 23.9% from Mexico and Canada and 18.7% from Europe. Unsurprisingly, imports decrease...

Copyright © 2025 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.